VX 702
| CAS No. | 745833-23-2 | Cat. No. | BCP28564 |
| Name | VX 702 | ||
| Synonyms | VX702; VX-702; | ||
| Formula | C19H12F4N4O2 | M. Wt | 404.31 |
| Description | VX-702, one of a series of second-generation, is an orally active p38 MAP kinase inhibitors, for the potential treatment of inflammation, rheumatoid arthritis and cardiovascular diseases. VX-702 prevents activation of p38MAPK and decrements in many platelet storage parameters after exposure to 16 °C without agitation for 24 h. | ||
| Pathways | MAPK Pathway | ||
| Targets | p38 MAPK | ||
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.